Real-world effectiveness of peginterferon [alpha]-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies

Marotta, P ; Bailey, R ; Elkashab, M ; Farley, J ; Feinman, S V ; Peltekian, K ; Poliquin, M ; Witt-sullivan, H ; Rampakakis, E ; Drolet, M ; Cooper, C

European journal of clinical microbiology & infectious diseases, 2016-04, Vol.35 (4), p.597 [Periódico revisado por pares]

Heidelberg: Springer Nature B.V

Texto completo disponível